KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Goodwill: 2009-2024

Historic Goodwill for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $196.2 million.

  • Biomarin Pharmaceutical's Goodwill changed negligibly% to $196.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $196.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $196.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Goodwill stood at $196.2 million for FY2024, which was down 0.00% from $196.2 million recorded in FY2023.
  • In the past 5 years, Biomarin Pharmaceutical's Goodwill registered a high of $196.2 million during FY2020, and its lowest value of $196.2 million during FY2020.
  • Moreover, its 3-year median value for Goodwill was $196.2 million (2024), whereas its average is $196.2 million.
  • Data for Biomarin Pharmaceutical's Goodwill shows a maximum YoY fell of 0.43% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Biomarin Pharmaceutical's Goodwill stood at $196.2 million in 2020, then remained steady at $196.2 million in 2021, then remained steady at $196.2 million in 2022, then remained steady at $196.2 million in 2023, then remained steady at $196.2 million in 2024.